معرفی
Sarah Akerman, MD, serves as Clinical Assistant Professor of Psychiatry within the Department of Psychiatry at Dartmouth College's Geisel School of Medicine. Her academic role bridges clinical practice and research with a focus on aging populations and psychiatric pharmacology.
Education:
- MD, University of Miami Miller School of Medicine
- BA, Tufts University
Research Focus:
Dr. Akerman's work centers on geriatric psychiatry and psychopharmacology, with distinctive expertise in Nordic aging studies. Her research examines longevity determinants in Western Finland, socioecological factors in caregiver support systems, and innovative approaches to managing antipsychotic side effects. She actively investigates sleep disorders like narcolepsy while exploring opioid antagonists' role in mitigating medication-induced weight gain.
Publication Trends:
Her 2023-2025 publications reveal three dominant threads: (1) Nordic aging research examining Blue Zones and caregiver burden across Finland/Sweden, (2) clinical pharmacology studies targeting antipsychotic-associated metabolic risks through samidorphan combinations, and (3) sleep disorder therapeutics development. These works demonstrate consistent international collaboration and methodological diversity spanning longitudinal cohort studies, meta-analyses, and patient-centered trial designs.
Professional Context:
As part of Dartmouth's psychiatry faculty, Dr. Akerman contributes to the institution's research ecosystem that recently secured a $12M NIH COBRE grant for implementation science. Her work intersects with Geisel's initiatives in mental health innovation, including collaborations with the play2Prevent Lab focused on digital therapeutics for neurodiverse populations.
